Endoscopic Retrograde Cholangiopancreatography

Recruiting now

Conditions studied: Gastro-Intestinal Disorder

In brief

The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.

Key facts

Study ID

NCT07490132

Run by

Methodist Health System

People needed

100

Starts

2026-02-01

Expected to finish

2028-02-01

Last updated by the study team

2026-03-24

Who can join

Age: 15 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients >15 years Included in MDI's Registry Underwent ERCP between January 1, 2000 through December 31, 2025

You may not qualify if…

• Patients <15 years Patients in which cannulation was via a surgical anastomosis Patients in which cannulation was not attempted due to gastric outlet obstruction, the main papilla not found, or the minor papilla was not found will be excluded.

Where it is running

• Methodist Dallas Medical Center- Clinical Research Institute — Dallas, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.